These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 6713036)
21. Plasma phenylethylamine and phenylalanine in chronic schizophrenic patients. Szymanski HV; Naylor EW; Karoum F Biol Psychiatry; 1987 Feb; 22(2):194-8. PubMed ID: 3814669 [TBL] [Abstract][Full Text] [Related]
22. Penetration of phenylacetic acid across the blood-cerebrospinal fluid barrier. Pedemonte WA; Mosnaim AD; Bulat M Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):111-6. PubMed ID: 935645 [TBL] [Abstract][Full Text] [Related]
23. Correlations of plasma and urinary phenylacetic acid and phenylethylamine concentrations with eating behavior and mood rating scores in brofaromine-treated women with bulimia nervosa. Davis BA; Kennedy SH; D'Souza J; Durden DA; Goldbloom DS; Boulton AA J Psychiatry Neurosci; 1994 Jul; 19(4):282-8. PubMed ID: 7918350 [TBL] [Abstract][Full Text] [Related]
25. Time study of the urinary excretion of 3,4-dimethoxyphenylethylamine and 3,4-dimethoxyphenylacetic acid by schizophrenic and normal individuals. Vogel WH; Ahlberg CD; Horwitt MK Int J Neuropsychiatry; 1967 Jun; 3(3):292-7. PubMed ID: 6034737 [No Abstract] [Full Text] [Related]
26. Pathways linking L-phenylalanine and 2-phenylethylamine with p-tyramine in rabbit brain. Silkaitis RP; Mosnaim AD Brain Res; 1976 Sep; 114(1):105-15. PubMed ID: 963535 [TBL] [Abstract][Full Text] [Related]
27. Cross-cultural study of a biochemical abnormality in paranoid schizophrenia. Jeste DV; Doongaji DR; Panjwani D; Datta M; Potkin SG; Karoum F; Thatte S; Sheth AS; Apte JS; Wyatt RJ Psychiatry Res; 1981 Dec; 5(3):341-52. PubMed ID: 6948314 [TBL] [Abstract][Full Text] [Related]
28. Cerebrospinal fluid levels of phenylacetic acid in mental illness: behavioral associations and response to neuroleptic treatment. Sharma RP; Faull K; Javaid JI; Davis JM Acta Psychiatr Scand; 1995 May; 91(5):293-8. PubMed ID: 7639084 [TBL] [Abstract][Full Text] [Related]
29. The schizophrenia syndrome. Examples of biological tools for subclassification. Wyatt RJ; Potkin SG; Kleinman JE; Weinberger DR; Luchins DJ; Jeste DV J Nerv Ment Dis; 1981 Feb; 169(2):100-12. PubMed ID: 7009783 [TBL] [Abstract][Full Text] [Related]
30. Phenylacetate catabolism in Rhodococcus sp. strain RHA1: a central pathway for degradation of aromatic compounds. Navarro-Llorens JM; Patrauchan MA; Stewart GR; Davies JE; Eltis LD; Mohn WW J Bacteriol; 2005 Jul; 187(13):4497-504. PubMed ID: 15968060 [TBL] [Abstract][Full Text] [Related]
31. [Platelet serotonin in endogenous depressive patients and normal controls]. Spatz H; Spatz N Acta Psiquiatr Psicol Am Lat; 1995 Sep; 41(3):230-6. PubMed ID: 8728799 [TBL] [Abstract][Full Text] [Related]
32. Metabolism of 2-phenylethylamine to phenylacetic acid, via the intermediate phenylacetaldehyde, by freshly prepared and cryopreserved guinea pig liver slices. Panoutsopoulos GI In Vivo; 2004; 18(6):779-86. PubMed ID: 15646820 [TBL] [Abstract][Full Text] [Related]
33. Biochemistry and the schizophrenia. Old concepts and new hypothesis. Berger PA J Nerv Ment Dis; 1981 Feb; 169(2):90-9. PubMed ID: 7009786 [TBL] [Abstract][Full Text] [Related]
34. Longitudinal effect of amitriptyline and fluoxetine treatment on plasma phenylacetic acid concentrations in depression. Davis BA; Boulton AA; Yu PH; Durden DA; Keegan DL; Bowen RC; Blackshaw S; D'Arcy C; Remillard AJ; Dayal N Biol Psychiatry; 1991 Sep; 30(6):600-8. PubMed ID: 1932407 [TBL] [Abstract][Full Text] [Related]
35. Phenylethylamine and schizophrenia. O'Reilly RL; Davis BA Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):63-75. PubMed ID: 7906896 [TBL] [Abstract][Full Text] [Related]
36. Determination of phenylacetic acid in cerebrospinal fluid by gas chromatography-mass spectrometry. Kawabata M; Kobayashi K; Shohmori T Acta Med Okayama; 1986 Oct; 40(5):271-6. PubMed ID: 3788666 [TBL] [Abstract][Full Text] [Related]
37. Phenylpyruvic acid may be a direct precursor of mandelic acid without intermediate transamination of phenylalanine. Godwin BL; Ruthven CR; Sandler M Biochem Pharmacol; 1993 Dec; 46(11):2109-10. PubMed ID: 8267662 [TBL] [Abstract][Full Text] [Related]
38. Longitudinal urinary excretion of some "trace" acids in a human male. Davis BA; Boulton AA J Chromatogr; 1981 Feb; 222(2):161-9. PubMed ID: 7251734 [TBL] [Abstract][Full Text] [Related]
39. Effect of phenylalanine and its metabolites on the proliferation and viability of neuronal and astroglial cells: possible relevance in maternal phenylketonuria. Oberdoerster J; Guizzetti M; Costa LG J Pharmacol Exp Ther; 2000 Oct; 295(1):295-301. PubMed ID: 10991993 [TBL] [Abstract][Full Text] [Related]
40. Metabolism of an amino acid with antidepressant properties. Borison RL; Maple PJ; Havdala HS; Diamond BI Res Commun Chem Pathol Pharmacol; 1978 Aug; 21(2):363-6. PubMed ID: 694233 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]